NEW YORK, Oct. 12, 2013 /PRNewswire/ --
Atossa Genetics, Inc.
Lifshitz Law Firm announces an
investigation into possible breaches of fiduciary duty by the board
of directors of Atossa Genetics, Inc. ("Atossa" or the
"Company"). On October 4, 2013,
Atossa announced it had commenced the voluntary recall of the
ForeCYTE Breast Health Test Mammary Aspiration Specimen Cytology
Test. In February 2013, the
Company received a warning letter from the FDA. The FDA
raised concerns about (1) the current instructions for use ("IFU");
(2) certain promotional claims used to market these devices; and
(3) the need for FDA clearance for certain changes made to the
Nipple Aspirate Fluid specimen collection process identified in the
current IFU. Atossa will remove existing product from the
market until FDA's concerns are addressed.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or
by sending an e-mail including your contact information to:
info@jlclasslaw.com.
Francesca's Holdings Corporation
Lifshitz Law
Firm announces that a class action suit was filed in the United
States District Court for the Southern District of New York, alleging that Francesca's Holdings
Corporation ("FRAN") issued false and misleading statements to
investors between March 20, 2013 and
September 3, 2013, inclusive (the
"Class Period") by failing to disclose that: (i) spring and summer
weather and a competitive back-to-school retail environment weighed
on same-store sales growth; and (ii) same-store sales were
declining.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or
by sending an e-mail including your contact information to:
info@jlclasslaw.com.
Greenway Medical Technologies, Inc.
Lifshitz Law
Firm announces an investigation into possible breaches of fiduciary
duty in connection with the proposed sale of Greenway Medical
Technologies, Inc. ("GWAY") to Vista Equity Partners in a
transaction valued at approximately $644
million or $20.35 per share in
cash.
Lifshitz Law Firm's investigation is focused on whether the
proposed deal provides adequate value to GWAY's shareholders.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or
by sending an e-mail including your contact information to:
info@jlclasslaw.com.
PVR Partners, L.P.
Lifshitz Law Firm announces
an investigation into possible breaches of fiduciary duty in
connection with the proposed sale of PVR Partners, L.P. ("PVR") to
Regency Energy Partners LP in a unit-for-unit transaction plus a
one-time cash payment to PVR unitholders that collectively imply a
value on October 10, 2013 for PVR of
approximately $5.6 billion, including
the assumption of net debt of $1.8
billion.
Lifshitz Law Firm's investigation is focused on whether the
proposed deal provides adequate value to PVR's shareholders.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or
by sending an e-mail including your contact information to:
info@jlclasslaw.com.
Lifshitz Law Firm is a New York
based law firm with significant experience representing investors
in merger-related shareholder class actions, shareholder derivative
actions, and securities fraud class actions. For more
information about the firm, please visit our website at
www.jlclasslaw.com.
ATTORNEY ADVERTISING. © 2013 Lifshitz Law
Firm. The law firm responsible for this advertisement is
Lifshitz Law Firm, 18 East 41st Street, New York, New York 10017, (212)
213-6222. Prior results do not guarantee or predict a similar
outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law Firm
Phone: 212-213-6222
Email: info@jlclasslaw.com
SOURCE Lifshitz Law Firm